Cancer burden of major cancers in China: A need for sustainable actions

Wiley - Tập 40 Số 5 - Trang 205-210 - 2020
Maomao Cao1, Li He1, Dianqin Sun1, Wanqing Chen1
1Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021 P. R. China

Tóm tắt

AbstractCancer is still a major health problem in China although numerous efforts have been made for its prevention and control. Findings from this study showed that lung cancer remains the most common type of cancer diagnosed, and was attributed to nearly 30% of all cancer‐related deaths. The incidence of the five most common cancers, in China, in 2015, including cancers of the lungs, stomach, colorectum, liver and breast, accounted for almost 60% of all cancers diagnosed. The high cancer burden in China highlights the need for further improvement in health education, professional training and the building up an anti‐cancer network for introducing and implementing sustainable actions for cancer control.

Từ khóa


Tài liệu tham khảo

10.1186/s40880-019-0368-6

10.1016/S0140-6736(19)30427-1

FerlayJ ErvikM LamF ColombetM MeryL PiñerosMet al.Global Cancer Observatory: Cancer Today. Lyon France: International Agency for Research on Cancer.2018.https://gco.iarc.fr/today(accessed Nov 15 2019). Accessed 8 144.

10.3322/caac.21590

Zheng R, 2019, Report of cancer epidemiology in China, 2015, Chin J Oncol, 41, 19

10.1016/S1470-2045(13)70567-9

10.3322/caac.21338

Zhang Y, 2015, Burden of colorectal cancer in China, Chin J Epidemiol, 36, 709

Shao HY, 2016, Age‐period‐cohort modeling study on the mortality of hepatic carcinoma from 1991‐2011, Chin J Cancer Prev Treat, 23, 1465

10.1007/s10549-008-0303-z

Zeng HM, 2018, Trend analysis of age of diagnosis for liver cancer in cancer registry areas of China, 2000‐2014, Chin J Prev Med, 52, 573

Zhang SW, 2018, Trend analysis on incidence and age at diagnosis for lung cancer in cancer registration areas of China, 2000‐2014, Chin J Prev Med, 52, 579

10.1016/S0140-6736(16)32226-7

Chen R, 2019, Analysis of incidence and mortality of esophageal cancer in China, 2015, Chin J Prev Med, 53, 1094

The State Council.National Mid and Long‐term Plan for Prevention and Treatment of Chronic Disease (2017‐2025).http://www.nhc.gov.cn/bgt/gwywj2/201702/63b05a3bc7814a3686d5d37f0211f88c.shtml(accessed Jan 18 2020; in Chinese).

The State Council.The Report on the Work of the Government.http://www.gov.cn/zhuanti/2019qglh/2019lhzfgzbg/index.htm(accessed Jan 18 2020; in Chinese).

The State Council.Healthy China Initiative to transform industry.http://english.www.gov.cn/policies/policywatch/201907/24/content_WS5d37c99cc6d00d362f668c57.html(accessed Jan 18 2020).

The State Council.The Implementation Plan for Cancer Prevention and Treatment (2019‐2022).http://www.nhc.gov.cn/jkj/s5878/201909/2cb5dfb5d4f84f8881897e232b376b60.shtml(accessed Jan 18 2020; in Chinese).

10.1177/1010539516650724

10.1038/ajg.2013.160

10.1080/07315724.2012.10720447

10.1016/S2214-109X(18)30488-1

Shen X, 2017, Spatial Analysis of Regional Factors and Lung Cancer Mortality in China, 1973‐2013, Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology., 26, 569, 10.1158/1055-9965.EPI-16-0922

Mackay J, 2016, China: the tipping point in tobacco control, British medical bulletin, 120, 15, 10.1093/bmb/ldw043

Wang M, 2019, Trends in smoking prevalence and implication for chronic diseases in China: serial national cross‐sectional surveys from 2003 to 2013, The Lancet Respiratory medicine, 7, 35, 10.1016/S2213-2600(18)30432-6

10.1016/S0140-6736(18)30010-2

Abbasi J, 2020, Artificial Intelligence Improves Breast Cancer Screening in Study, JAMA, 323, 499, 10.1001/jama.2020.0370

He L, 2020, Attitudes towards HPV self‐sampling among women in Chengdu, China: A cross‐sectional survey, J Med Screen., 096914131989554

10.1016/S2214-109X(18)30127-X

10.7326/M14-0558

10.1258/096914103771773320

Ji M, 2018, Mass screening for liver cancer: results from a demonstration screening project in Zhongshan City, China. Sci Rep., 8, 12787, 10.1038/s41598-018-31119-9

CouncilTS.China pushes forward reforms to expand access to anti‐cancer drugs.http://english.www.gov.cn/policies/policy_watch/2019/02/12/content_281476518960968.htm(accessed Feb 13 2020).

10.2147/CLEP.S106258

10.3390/ijerph15071368

Thông tin
Thông tin xuất bản

Wiley

Tập 40 Số 5

205-210

Thông tin tác giả